News Contact Us Careers Get E-Mail alerts Search

ADMA Biologics, Inc.

  • Home
  • About Us
    • About ADMA Biologics
    • What We Do
    • Who We Are
      • Senior Leadership Team
      • Board of Directors
      • Scientific Advisory Board
      • Compliance
  • Our Products
    • Products Overview
    • About Primary Immunodeficiency Disease (PI)
    • ASCENIV™
    • BIVIGAM®
    • Nabi-HB®
  • Manufacturing
    • Our Patented Process
    • Contract Manufacturing and Aseptic Fill-Finish
  • Plasma & IVIG
    • What Is Plasma?
    • Immune Globulin's Critical Role
    • Immune Globulin Production
  • Medical Affairs
    • Medical Affairs Overview
    • Publications
  • ADMA BioCenters
  • Investors
    • Overview
    • Press Releases
      • Email Alerts
    • Company Info
      • Profile
      • Presentation
      • Management Team
      • Contacts
      • FAQs
    • Analyst Coverage
    • Events & Webcasts
    • Financial Info
      • Financial Results
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Annual Reports
    • Stock Info
      • Stock Data & Quote
      • Charts
      • Historical Data
    • SEC Filings
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Board of Directors
      • Board Committees
      • Documents
  • News
  • Contact Us
  • Careers
  • Get E-Mail alerts
  • Search

You are now leaving www.admabiologics.com

The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?

Yes No

News

Investors

Investors

  • Overview
  • Press Releases
    • Email Alerts
  • Company Info
    • Profile
    • Presentation
    • Management Team
    • Contacts
    • FAQs
  • Analyst Coverage
  • Events & Webcasts
  • Financial Info
    • Financial Results
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Annual Reports
  • Stock Info
    • Stock Data & Quote
    • Charts
    • Historical Data
  • SEC Filings
    • SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Documents
  • Press Releases

  • Email Alerts

Click below for current and archived news related to the company.

ADMA Biologics to Report First Quarter 2022 Financial Results on May 11, 2022
May 04, 2022 7:00am EDT
ADMA Announces Live Poster Presentation and Symposium on Real-World Experience with ASCENIV™ at CIS 2022
Apr 01, 2022 7:00am EDT
ADMA Biologics Announces FDA Approval of Extended Shelf Life for ASCENIV™ & BIVIGAM<sup>®</sup> from 24 to 36 Months
Mar 25, 2022 7:00am EDT
ADMA Biologics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update, Including $175M Debt Refinance with Hayfin Capital Management
Mar 24, 2022 4:05pm EDT
ADMA Biologics to Report Fourth Quarter and Full Year 2021 Financial Results on March 24, 2022
Mar 21, 2022 7:00am EDT
ADMA BioCenters Receives FDA Approval for Its Fifth Plasma Collection Center, Located in Conyers, GA
Mar 07, 2022 4:05pm EST
ADMA Biologics Announces Record Preliminary Fourth Quarter and Full Year 2021 Revenues and Provides 2022 Business Update
Jan 19, 2022 7:00am EST
ADMA BioCenters Receives FDA Approval for Its Fourth Plasma Collection Center Located in Goose Creek, SC
Jan 18, 2022 7:00am EST
ADMA Biologics Adopts Limited Duration Stockholder Rights Plan
Dec 21, 2021 7:00am EST
ADMA Biologics Provides Update on Global Intellectual Property Portfolio
Dec 09, 2021 7:00am EST
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...25
  • Next
ADMA Biologics, Inc.
Twitter logo
LinkedIn logo
About Us Our Products Manufacturing Plasma & IVIG Medical Affairs Investors HCP Disclosure Reporting Privacy Policy Disclaimer Sitemap Contact Us Connect with Us Email Alerts RSS
Best places to work
Bio NJ

2020 Innovator Award

50 fastest companies
2022 Fast 500 Deloitte
Bio Florida

Named 2019 Company of the Year

2023 Americas' fastest growing companies, Financial Times

© Copyright 2023 ADMA Biologics, Inc.
Ramsey, NJ Offices 201-478-5552
Boca Raton, FL Offices 561-989-5800
info@admabio.com